Literature DB >> 9822156

Motor and learning dysfunction during postnatal development in mice defective in dopamine neuronal transmission.

K Nishii1, N Matsushita, H Sawada, H Sano, Y Noda, T Mamiya, T Nabeshima, I Nagatsu, T Hata, K Kiuchi, H Yoshizato, K Nakashima, T Nagatsu, K Kobayashi.   

Abstract

Mice lacking expression of tyrosine hydroxylase (TH), the first and rate-limiting enzyme of the catecholamine biosynthetic pathway, in dopaminergic neuronal cell types were generated by a transgenic rescue approach to clarify the role of dopamine signaling during postnatal development. Introduction of the TH transgene directed by the dopamine beta-hydroxylase gene promoter into TH knockout mice restored noradrenaline and adrenaline synthesis, preventing perinatal lethality and cardiac dysfunction in the knockout mice. Lack of TH expression in the cells that normally express the dopaminergic phenotype resulted in a marked reduction of dopamine accumulation in the tissues, which led to multiple behavioral abnormalities at the juvenile stage. These abnormalities were characterized by a reduction in spontaneous locomotor activity, blockade of methamphetamine-induced hyperactivity, cataleptic behavior, and defects in active avoidance learning. In contrast, development of the pituitary gland as well as production and secretion of the pituitary peptide hormones dependent on hypothalamic dopaminergic control were normally maintained, despite defective dopamine synthesis. These results demonstrate that dopamine neurotransmission is essential for controlling spontaneous and voluntary movement and associative learning during postnatal development through the nigrostriatal and mesocorticolimbic pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822156     DOI: 10.1002/(SICI)1097-4547(19981115)54:4<450::AID-JNR3>3.0.CO;2-B

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  10 in total

1.  Modest neuropsychological deficits caused by reduced noradrenaline metabolism in mice heterozygous for a mutated tyrosine hydroxylase gene.

Authors:  K Kobayashi; Y Noda; N Matsushita; K Nishii; H Sawada; T Nagatsu; D Nakahara; R Fukabori; Y Yasoshima; T Yamamoto; M Miura; M Kano; T Mamiya; Y Miyamoto; T Nabeshima
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

2.  Neonatal lipopolysaccharide exposure induces long-lasting learning impairment, less anxiety-like response and hippocampal injury in adult rats.

Authors:  K-C Wang; L-W Fan; A Kaizaki; Y Pang; Z Cai; L-T Tien
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

3.  Peripheral assessment of the genes AQP4, PBP and TH in patients with Parkinson's disease.

Authors:  S Thamizh Thenral; A J Vanisree
Journal:  Neurochem Res       Date:  2011-11-15       Impact factor: 3.996

4.  Subthalamic neurons coordinate basal ganglia function through differential neural pathways.

Authors:  Yasunobu Yasoshima; Nobuyuki Kai; Shigetaka Yoshida; Sadao Shiosaka; Yoshimasa Koyama; Yukihiko Kayama; Kazuto Kobayashi
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

5.  Therapeutic Effects of Quetiapine and 5-HT1A Receptor Agonism on Hyperactivity in Dopamine-Deficient Mice.

Authors:  Yukiko Ochiai; Masayo Fujita; Yoko Hagino; Kazuto Kobayashi; Ryoichi Okiyama; Kazushi Takahashi; Kazutaka Ikeda
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

Review 6.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

Review 7.  Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.

Authors:  Toshiharu Nagatsu; Ikuko Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2016-08-04       Impact factor: 3.575

8.  Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.

Authors:  Yoko Hagino; Shinya Kasai; Masayo Fujita; Susumu Setogawa; Hiroshi Yamaura; Dai Yanagihara; Makoto Hashimoto; Kazuto Kobayashi; Herbert Y Meltzer; Kazutaka Ikeda
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 9.  The catecholamine system in health and disease -Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes.

Authors:  Toshiharu Nagatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2007-01-12       Impact factor: 3.493

10.  Light/dark phase-dependent spontaneous activity is maintained in dopamine-deficient mice.

Authors:  Masayo Fujita; Yoko Hagino; Taishi Takeda; Shinya Kasai; Miho Tanaka; Yukio Takamatsu; Kazuto Kobayashi; Kazutaka Ikeda
Journal:  Mol Brain       Date:  2017-10-16       Impact factor: 4.041

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.